Pre-Conference Discussion Day

Progressive Fibrotic – Interstitial Lung Disease Workshop
The Potential & Practicality of Transferring IPF Concepts to Broader Fibrosing Lung Disease

Kevin Flaherty

1.30 Patient Focused Drug Development “Voice of the Patient (VOP)” - With Activities of Daily Living (ADL) as a Regulatory Primary Endpoint for Phase 3 in IPF

 

Kevin Flaherty Professor, Division of Pulmonary & Critical Care Medicine University of Michigan

T

2.30 Biomarkers of Disease Progression in IPF & SSc

 

Thiru Ramalingam Fibrosis Cross-Functional Team Leader Genentech

Mary Salvatore

3.00 Fibrotic Patterns for Diagnosis, Prognosis & Disease Monitoring

 

Mary Salvatore Associate Professor, Radiology Columbia University Medical Center

3.30 Group Discussion: Lumping Versus Splitting

Kevin Flaherty

Kevin Flaherty Professor, Division of Pulmonary & Critical Care Medicine University of Michigan

ganesh-raghu

Ganesh Raghu Director, Interstitial Lung Diseases/ Sarcoid, Pulmonary Fibrosis Program University of Washington

4.00 Pre-Conference Discussion Ends